- Home
- BRT vs SIGA Comparison
BRT vs SIGA Comparison
Compare BRT & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRT | SIGA |
|---|---|---|
| Founded | 1972 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.2M | 309.8M |
| IPO Year | 1994 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BRT | SIGA |
|---|---|---|
| Price | $14.91 | $3.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | 47.1K | ★ 631.0K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | 7.03% | ★ 13.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $97,028,000.00 | N/A |
| Revenue This Year | $3.82 | N/A |
| Revenue Next Year | $5.35 | $224.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.46 | N/A |
| 52 Week Low | $13.18 | $3.40 |
| 52 Week High | $16.69 | $9.62 |
Technical Indicators
Market Signals| Indicator | BRT | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 51.21 | 39.41 |
| Support Level | $14.27 | N/A |
| Resistance Level | $15.01 | $4.84 |
| Average True Range (ATR) | 0.46 | 0.16 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 50.03 | 30.91 |
Price Performance
Historical ComparisonAbout BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.